An Indian hospital, in a breakthrough, implants a Bio-Resorbable Vascular Scaffold (BVS) in a patient. Once the vessel heals, the scaffold starts dissolving in heart artery.
The doctors in India have announced about their competence in implanting soluble stent. This is a progressive procedure to unclog the heart arteries. BVS, a revolutionary device, opens a clogged vessel and restores blood flow. The device also provides support while it heals. As the bio-resorbable scaffold slowly metabolized and finally dissolves forming water and carbon dioxide in the body.
“Treatments for coronary artery disease have come a long way from the days of balloon angioplasties and metal stents. However, a dissolving stent like BVS leaves no foreign body inside the human body, as the clogged artery can be enlarged and supported effectively, without the stent leaving any fragments behind in the blood stream.” explained Dr. B.V. Manjunath, interventional cardiologist. Interventional cardiologist, Dr. R. Purushotham added, “The device is made of polylactide, a proven biocompatible material that is commonly used in medical implants, such as dissolving sutures. Since a permanent implant is not left behind, a vessel treated with a BVS ultimately may have the ability to move, flex and pulsate similar to an untreated vessel.”
What’s At Stake Cardiovascular Disease is one major cause of death globally. A survey also predicts that by 2030, about 2.36 crore people, every year, will die from cardiovascular disease. The increase in number of deaths will be seen in the South-East region of Asia.
But What Is BVS? BVS is a very unique device used for the CAD (coronary artery disease) treatment. This device operates by restoring blood flow to the heart alike to a metallic stent. But, as this dissolves into the body, the treated vessel resume more natural movement and function as there is no permanent metallic stent. The vessel may contract and expand as according to the requirement of flow of blood to the heart during normal activities like exercising. Therefore, diagnostic and treatment options are widened. The requirement for long-term treatment through anti-clotting medications may be eliminated and future treatment would be possible by a permanent implant.